Erythropoiesis-Stimulating Drugs
In 2006, the Food and Drug Administration (FDA) issued an advisory regarding treatment targets for erythropoiesis-stimulating drugs. These drugs include epoetin alfa (Procrit, Epogen, and Eprex) and darbepoetin alfa (Aranesp). They are used to treat severe anemia caused by other diseases, such as chronic kidney disease.
Two 2006 studies in the New England Journal of Medicine indicated that aggressive dosing to completely normalize anemia (hemoglobin level...
Read more »...hope to people with autosomal dominant polycystic kidney disease (ADPKD). ADPKD is a... Read more »
...would indicate a problem. Another screening includes ultrasonography where doctors send sound... Read more »
When we have healthy kidneys, little or no protein appears in the urine. But protein in the urine... Read more »
...the issue has targeted both of the arteries to the kidneys. Symptoms and Causes When the... Read more »
...there's an increased risk of renal insufficiency (kidneys not working well) and/or an increased... Read more »
(Ivanhoe Newswire) -- A technique used to prevent stroke in children with sickle cell disease reduced stroke incidence by 90 percent. Transcranial... Read summary »
(Ivanhoe Newswire) -- When a patient is treated for kidney cancer, surgeons remove the affected kidney as part of treatment. However, new research... Read summary »
(Ivanhoe Newswire) -- A once-a-month treatment could be all it takes to improve the quality of life for people with severe kidney disease.... Read summary »
(Ivanhoe Newswire) -- A protein found in common garden peas could be the key to saving the lives of millions of people who suffer from high blood... Read summary »
(Ivanhoe Newswire) -- They say age is just a number, right? Well, researchers say age really doesn't matter when it comes to minimally invasive... Read summary »